… is an important regulatory organ in maitaining cardiovascular homeostasis and that endothelial
dysfunction is present in several cardiovascular diseases. The endothelium, which was …

… of specific growth factors [vascular endothelial growth factors (VEGFs) or other growth factors
stimulating endothelial cell proliferation] or cellular elements (in-vitro expanded endothelial …

… angiogenesis, the development of antagonists for VEGF in the treatment of cancer, and the
use of VEGF therapeutically in cardiovascular diseases are now the focus of major research …

… fact that the endothelium can actively promote migration and growth of … why, in spite of an
intact endothelium in atherosclerosis, proliferative … Endothelium and cardiovascular disease …

… Heart valves are lined with a specialized endothelium derived … endothelial growth factor
receptor-2]) progenitor cells that originate from cardiac mesoderm 4 ; these valvular endothelial …

… , there are several outstanding problems that proponents of VEGF therapy need to consider
and that are likely to modify our understanding of the role of VEGF in cardiovascular disease …

… , endothelial dysfunction and elevated plasma CRP levels indicate increased risk of
cardiovascular disease. … been shown to reduce CRP levels and may improve endothelial function. …

… platelet endothelial cell … endothelial growth factor receptor 2 (VEGFR2) 32,33 are used to
define the EC lineage, whereas transcription factor 21 (TCF21), platelet-derived growth factor …

… in patients with risk factors for cardiovascular disease (eg, hypercholesterolemia, …
disease and summarizes strategies currently being used to measure and improve endothelial …

… Recent data indicate that vascular endothelial growth factor (VEGF), the most-critical factor
for vasculogenesis and angiogenesis [14-16], is an important factor for the mobilization of …